Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for the heads up. I have also been weary of it since the bliss on it from last Friday. But it responded well. These are just some of the stocks that I am watching. I will enter a few hopefully in the morning. With all these stocks taking off lately it is hard to decide which to get into and if the run will be over by the time I decide to enter.
Good luck
ICHC looks interesting also.
Share-Related Items Market Capitalization $461.0K Shares Outstanding 11.5M Float 7.80M
Price and Volume 52-Week Low
on 2-Jan-2001 $0.031 Recent Price $0.04 52-Week High
on 29-Mar-2000 $3.50 Daily Volume (3-month avg) 200.3K Daily Volume (10-day avg) 749.0K
inCHORUS.com Has Entered Into Negotiations for an Exclusive Licensing Agreement And/or Acquisition Agreement With Cyberradio.com, Inc. </bw/010116/ca_inchoru.html>
SYWI did a 10-1 forward split in Sep. It did not run post split. But this stock has been getting more exposure lately and if the estimate of 500,000 shares in the float is correct then we could see a nice run here.
Tuesday, January 16 2001 11:48pm ET - U.S. Markets Closed.SYSTEMS WEST INC (OTC BB:SYWI.OB) - More Info: N/A
Last Trade
3:35PM · 0.09 Change
+0.040000 (+80.00%) Prev Cls
0.050000 Volume
284,600 Div Date
N/A
Day's Range
0.040000 - 0.09 Bid
0.08 Ask
0.09 Open
0.050000 Avg Vol
N/A Ex-Div
Sep 26
52-week Range
0.01 - 0.85 Earn/Shr
N/A P/E
N/A Mkt Cap
N/A Div/Shr
N/A Yield
N/A
BHUB might still be a good play tomorrow. Year high of $5.00. Float of 2.2 mil, and a lot of interest this past week.
Recent Events
Jan 11 Price hit new 52-week low ($0.016)
Location
2939, Moss Rock
San Antonio, TX 78230
Phone: (210) 979-9228
Fax: (210) 979-6336
Email: investorrelations@thebighub.com
Employees (last reported count): 11
Financial Links
·Top Institutional Holders
·Top Mutual Fund Holders
·Historical Quote Data
·Raw SEC Filings at sec.gov
Competitors:
·Sector: Technology
·Industry: Computer Services
Company Website
·Home Page
·Search Yahoo! for related links...
Ownership
· Insider: 90%
More From Market Guide
·Highlights
·Performance
·Ratio Comparisons
Business Summary
The BigHub.com, Inc. seeks to become a compelling destination portal alternative on the Internet. The Company intends to host an array of affiliated shopping alternatives covering many categories of general and special merchandise as well as consumer credit and consumer insurance. The goal of the Company is to use Internet marketing and its proprietary search engine to engage Internet users and demonstrate to them the advantages of using the BigHub.com, Inc. either as their search engine of choice or their home page of choice. The Company is now in the process of upgrading its search engine intellectual property and related Internet site. The meta-search engine technology acquired by the Company enabled consumers to search multiple sites concurrently, but returned the results in a serial fashion. The most significant enhancement to the search engine, MegaSearch, by the Company is the ability to return summarized results.
More from Market Guide: Expanded Business Description
Financial Summary
The BigHub.com, Inc. develops and operates the meta-search engine known as the Internet Sleuth on the Internet at http://www.thebighub.com. For the nine months ended 7/30/00, revenues totalled $3.4 million, up from $15 thousand. Net loss from continuing operations before extraordinary item totalled $4.3 million, up from $1.7 million. Revenues reflect an increase in coupon sales. Higher loss reflects an increase in S/G/A attributable to an increase in overall business development activities.
More from Market Guide: Significant Developments
Officers [Insider Trade Data]
Position
Frank Denny, 65 Chairman, CEO
Mark Doumani, 33 Exec. VP, Bus. Devel.
Chet Howard, 56 Sr. VP-Fin., CFO, Sec.
David Burrows, 41 CTO
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:BHUB.OB As of 12-Jan-2001
Price and Volume
52-Week Low
on 11-Jan-2001 $0.016
Recent Price $0.028
52-Week High
on 14-Jan-2000 $5.00
Daily Volume (3-month avg) 68.3K
Daily Volume (10-day avg) 145.0K
Stock Performance
big chart [1d / 5d / 3mo / 1yr / 2yr]
52-Week Change -99.4%
52-Week Change
relative to S&P500 -99.4%
Share-Related Items
Market Capitalization $607.0K
Shares Outstanding 21.7M
Float 2.20M
Dividends & Splits
Annual Dividend none
Last Split none
Per-Share Data
Book Value (mrq*) $0.16
Earnings (ttm) $0.08
Earnings (mrq) -$0.07
Sales (ttm) $0.20
Cash (mrq*) $0.01
Valuation Ratios
Price/Book (mrq*) 0.18
Price/Earnings (ttm) 0.37
Price/Sales (ttm) 0.14
Income Statements
Sales (ttm) $3.39M
EBITDA (ttm*) -$762.0K
Income available to common (ttm) -$949.0K
Profitability
Profit Margin (ttm) -28.8%
Operating Margin (ttm) -25.5%
Fiscal Year
Fiscal Year Ends Oct 31
Most recent quarter
(fully updated) 30-July-2000
Most recent quarter
(flash earnings) 31-July-2000
Management Effectiveness
Return on Assets (ttm) -31.31%
Return on Equity (ttm) -226.28%
Financial Strength
Current Ratio (mrq*) 0.46
Debt/Equity (mrq*) 0.14
Total Cash (mrq) $276.0K
Short Interest
Shares Short N/A
See Profile Help for a description of each item above; K = thousands; M = millions; mrq = most-recent quarter; ttm = trailing twelve months; (as of 31-July-2000, except mrq*/ttm* items as of 30-July-2000)
SYTE, Patsy, I was just coming back to paste this insider buying when I noticed your response. SYTE does look promising.
7-Dec-00 MANLUNAS, FREDERICK
Chairman of the Board, Director, 10% Beneficial Owner 5,584,746
SYTE Acquired at $0.04/Share.
Paper gain of $212,946 at a fair market value of $0.08/share on 27-Dec-00.
SYTE looks promising. Sitestar shareholders will receive distribution of the new shares at a later date. Float around 3.5 mil. Trading at $.10.
Sitestar's Subsidiary Approves Merger
ENCINO, Calif.--(BUSINESS WIRE)--Jan. 16, 2001--
Sitestar Acts on Plan to Become Two Independent Public Companies,
Prepares for Proxy Statement Filing Shares of Spun-Off Company
to Be Traded Under Different Symbol
Sitestar Corp.'s (OTCBB:SYTE) subsidiary today filed a proxy statement as a first step toward completing the spinoff that Sitestar's board of directors approved last year.
The move will create an independent public company focused on content development, and will unlock value for shareholders.
Sitestar intends to merge its content services business, to be named Sitestar Applied Technologies, with its public subsidiary and spin it off to shareholders as an independent public company that will trade under its own separate symbol.
Sitestar shareholders will receive distribution of the new shares at a later date. Sitestar Applied Technologies will concentrate on the development of Web infrastructure by delivering an array of custom software and Web-enabling solutions to small to midsized businesses.
"In addition to consolidating Internet service providers in the mid-Atlantic region, we have built a thriving content services division. Separating our divisions into two independent public entities will allow each company to chart its own course and maximize shareholder value," said Clinton J. Sallee, Sitestar president and chief executive officer.
"Sitestar is very committed to creating value for its shareholders and is cognizant of its task to improve the financial well-being of its investors," added Sallee.
About Sitestar
Patsy, SKGV has me stumped also. Just waiting for some other type of news to see if it can get rolling.
good luck to you.
SYWI with a float of around 500,000 shares is loking good right now. Trading at $.065.
RMOO
FONX
WWFI
BWAY
Good luck
FONX is another stock that has been doing well as of last week. Last year I used to get into this stock on the dips. It was always a good one to play. It would drop below a dollar and then go back over.
I have been watching it regularly over the past few months. And they were getting PR's out but the stock kept going down. I thought about buying in last week when it was at $.30, now it is around $.60. PR's have been coming out about contract deals with big companies.
Good luck.
DNAP looks like it might be a good one to get into at least short term. I have seen a lot of interest for this stock on many boards this weekend.
I have no position. I figured that many of you might get bored with my SKGV and RMOO posts. So I have this one for you.
Good luck.
HERE IS WHY TO BUY DNAP...Listing on bb expected this week!
DNAP NEWINVESTORS GUIDE—DD LINKS
MAJOR WEB PAGES RELATED TO DNAP
dnap
http://www.dnaprint.com/
orchid biosciences inc
http://www.orchidbio.com/
orchid&exelixis develop snp code(™)kits
http://cnbc.com/news/news/conewsstory.html?sym=ORCH&id=010p3336
INVEST IN DNAP
email for free investment package= hresources@dnaprint.com
or call 1-877-362-3453(toll free)
all general questions for dnap email steve wagoner
swagoner@tbfcorp.net
dnaps vast new market
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=47460
investment club web page=
http://clubs.yahoo.com/clubs/dnaprintgenomicsinvestors
sec filings for dnap from 3nov00
http://www.secinfo.com/$/SEC/Registrant.asp?CIK=1127354
do your homework before buying any penny stock!!!a must read
http://www.allstocks.com/copia/html/the_basics_of_otcbb.html
10-kt annual report for dnap filed 28nov2000
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=41181
cash rich biotechs—new york times—dec. 23--2000
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=48198
dun&bradstreet reports on dnap
http://dodge.telebase.com/cgi-bin/dandb.cgi?FIELD1=dnap+geonomics&FIELD3=FL&P=P0020HX&submit1=Find&U=%5BIP%5D&Q=FREDGARNOCHG&SERVICE=FREDGAR&R=HF0
dnap mission statement
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=9893
open house presentation-2dec00-sarasota florida
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=55002
2dec00 summary of open house events http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=42296
reports from craig hall, (director of financial analysis-Tampa Bay Financial)[craig’s phone number is 941 341-0136 http://www.ragingbull.altavista.com/mboard/boards.cgi?read=15868&board=DNAP
18 burning questions answered re dnaps future
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=41795
great dnap investor links:
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=22034
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=23118
how will dnap generate income
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=44208
dnap trade marks-existing and applied for
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=43546
2dec dnap applies for 1st of many patents
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=43524
dnap’s partial patents pending list and growing
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=21559
the human genome investors portal
http://www.loonycat.com/Genomics.htm
institutional investing in dnap
http://www.lionshares.com/secmasdetails.cfm?CUSIP=23324Q103&SEARCH=symbol&sort=net_chg&order=DESC&records=15&FirstRow=1&LastRow=15&SID=DSUD001%203046476467211222000161411%20%20%20%20%2016A13EDA73C5B25A6ACBCB49845D34DDC&PID=
2dec00-wallstreetreporter interview with dnap ceo dr. tony frudakis
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=41886
time magazine 15jan01 on genomics
http://www.time.com/time/health/
dnap a $50 stock? allstock.com thinks it could be—a must read
http://www.allstocks.com/stockmessageboard/ubb/Forum15/HTML/000006.html
biotechs ready to soar
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=39771
pink sheets.com features dnap
http://www.pinksheets.com/quote/company_profile.jsp?symbol=DNAP
Pollyanna says yes to biotech
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=57245
dnap links on yahoo—lots of good stuff
http://google.yahoo.com/bin/query?p=dnaprint+genomics&hc=0&hs=0
clearstation rates danp
http://www.clearstation.com/cgi-bin/details?Event=peek&Symbol=DNAP&Refer=http://www.purepennies.com/
sock the stocks profiles dnap
http://www.sockthestocks.com/profiles/dnap.htm
daily prices for last 12 months
http://www.clearstation.com/cgi-bin/stock_price_enum?Symbol=DNAP
insider trader looks at dnap
http://www.insidertrader.com/freestuff/search.asp?search=1&criteria=DNAP
purepenny&3bagger rate dnap
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132938
Pennystockprofits assess dnap
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=15730
tipreporter rates dnap http://www.tipreporter.com/search.php?search=dnap
dnap on stocktribes hotlist for 21 weeks
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=24335
analysts tips and reports on dnap
http://www.tipreporter.com/search.php?search=dnap
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=15730
rules for otcbb membership
http://www.otcbb.com/MarketMakerServices/Rules/ServiceRules.stm#6500
why is dnap unique in the bio tech sector??
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=22654
could this be dnaps story?? basics are certainly there
http://quote.ragingbull.altavista.com/quote.cgi?mode=c&1003=SSOL&time=9&compidx=aaaaa%3A0&x=19&y=9
fbi district for dnap(Miami)—basher complaints-305-944-0101
NEWSLINKS GENERAL FOR DNAP
dnap company news
http://www.bell2bell.newsalert.com/bin/digest?Symbol=DNAP& =bell2bell news
http://quicken.excite.com/investments/quotes/?s=DNAP&t=0 =excite news
http://biz.yahoo.com/n/D/DNAP.html =yahoo news
bioinform news service
http://www.bioinform.com/
online journal of bioinformatics
http://www.cpb.uokhsc.edu/ojvr/xmlpaper.html#Sites
NEWSLINKS SPECIFIC EVENTS FOR DNAP
dnap&univ of miami collaborate in personalized medicine research
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=46132
pharmacogenomics collaboration agreement with fla. doctors
http://quicken.excite.com/investments/news/story/bw/?story=/news/stories/bw/20001108/a2087.htm&symbol=DNAP
dnap in barrons http://www.sockthestocks.com/profiles/dnapbarrons.ht m
UPCOMING EVENTS RELATED TO DNAP
cambridge health institute conference—3-9march2001—san francisco,ca
http://www.genometriconference.com/
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=28822
http://www.healthtech.com/2001/hgp/
TECHNICAL SITES RELATED TO DNAP
what is pharmacogenomics
http://www.ornl.gov/hgmis/medicine/pharma.html
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=31311
dnap is about pharmacogenomics
http://www.nigms.nih.gov/funding/medforyou.html
mit tech review explores pharmagogenomics
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=54989
adding dna to the Rx mix
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=15981
dnap to the rescue—dangerous drugs
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=45628
gene therapy cures type 1 diabetes in rats
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=40149
dnap and breast cancer
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=39983
stem cell research
http://www.stemcellresearchnews.com/index.html
personalized medicine no longer science fiction
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=25033
safe drugs that fit like a glove
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=11203
snipping away at human disease
http://www.usnews.com/usnews/issue/001023/snips.htm
a dna tradegy—dnap is about changing this story
http://www.fortune.com/fortune/2000/10/30/dru.html
protein powerhouse—the future of dnap and medicine
http://www.redherring.com/mag/issue84/mag-athersys-84.html
DNAP’S IMPRESSIVE BRAIN TRUST-WATCH IT GROW
dr dc rao, renowned biostatistician joins dnap board
http://www.biostat.wustl.edu/biostat/raodc.html
http://quicken.excite.com/investments/news/story/bw/?story=/news/stories/bw/20001122/a2032.htm&symbol=DNAP
http://research.medicine.wustl.edu/OCFR/Research.nsf/Alphabetical/?OpenView&StartKey=R&Count=33
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=39979
dr. ramin mirashemi, a new dnap addition—check this track record!
http://www.google.com/search?q=Ramin+Mirhashemi&hl=en&lr=&safe=off&start=0&sa=N
dnap lands tech guru & statistical geneticist, dr k.n. ponnuswamy
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=36194
dr.s.c. chandra-recognized expert on stochastic processes-inventor
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=56267
dr.jose arena joins dnap scientific advisory board 03 oct 2000
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=23532
dnap consultant member-robert preston white,pa-c
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=41789
sivamani natarajan ph.d—statistical geneticist
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=43539
scientific advisory board makeup
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=41862
DNAP COMPARED TO ITS TECHNICAL EQUALS, AND RIVALS:
genomica(gnom)nasdq-ipo29sept00($19)now$22
http://www.bell2bell.newsalert.com/bin/digest?Symbol=GNOM&
rosetta inpharmatics(rsta)nasdaq-last$14-12dec00
http://quicken.excite.com/investments/quotes/?Mod=20&S1=N&ticker=&symbol=RSTA&button=Go&choice=on
informax(inunx)nasdq-ipo-03oct00($16)now$23
http://www.bell2bell.newsalert.com/bin/digest?Symbol=INMX&
decode genetics inc( dcgn-nasdaq) $12 last
http://quicken.excite.com/investments/quotes/?Mod=20&S1=N&ticker=&symbol=dcgn&choice=on
incite genomics(incy)nasdq $37
http://www.bell2bell.newsalert.com/bin/digest?Symbol=INCY&
genentech(dna)($172)-2for1split 5 oct00-263million share float---dnap float = 269 million
http://www.bell2bell.newsalert.com/bin/digest?Symbol=DNA&
DNAP IN EUROPE
http://www.8ung.at/zockstocks/index2.htm
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=21485
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=24168
WHERE IS DNAP LOCATED—HOW DO YOU GET THERE?
great air fare rates round trip to sarasota
http://leisure.travelocity.com/RealDeals/Details/0,2941,TRAVELOCITY_AIR_449,00.html
dnaps new upscale digs in swinging sarasota, fla
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=21059
motel shopper link for sunny sarasota area
http://www.roomsaver.com/roomsaver/city/index.html?state=FL&city=Sarasota
location map of coconut ave digs
http://maps.yahoo.com/py/maps.py?BFCat=&Pyt=Tmap&newFL=Use+Address+Below&addr=900+COCONUT+AVE&csz=SARASOTA%2CFLORIDA%2C+34234&country=us&Get%A0Map=Get+Map
avis rent a car sarasota
http://www.avis.com/cgi-bin/maps_and_directions/driving_maps/us_locations/mqinterconnect
INTELLIGENT ADVICE OR BIASED ROT?KNOW THE DIFFERENCE OR HOW TO USE THESE MESSAGE BOARDS
complain to the fbi-phone305-944-0101(miami field office)
email suspected lying-sham efforts,etc to your federal govt(it,s called the sec) at enforcement@sec.gov
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132869
get the mob out of microcaps
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132789
crush naked shorting –stop being screwed without even knowing it—read me
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132581
suspicious sounding codswallop?? ask them to take the universal basher quiz!!!!
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132816
dnap has unusually good promise—accounting for the sad fact that were in “basher heaven”-read me
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132818
sec offers tips on how to avoid scams on the internet—good article
http://www.sec.gov/consumer/cyberfr.htm
CONTENTS
1.BACKGROUND
2.FOUNDERS
3.PRODUCTS&SERVICES
1.BACKGROUND
DNAPrint genomics is a young e-biotech company based in southwest Florida. We are developing an informatics platform system that will provide dynamic solutions for disease gene discovery, genetic predisposition and genetic analysis testing. Our work has real-life application to the germinating field of Personalized Medicine and will help lay the foundation for a brand-new area of medical research called Phenomics.
The PhenomeSM platform system that we are developing will help identify an individual predisposed to develop cancer before the onset of illness so that lifestyles can be altered and/or preventative measures taken. It will be used to identify individuals who are incompatible with certain drug treatments before the drugs are prescribed and damage is done. It will be used to tease out important genetic determinants associated with complex genetic diseases, so that drugs can be developed to target these genes.
Our aim is ambitious. By partnering our platform with biotech/pharma, we will participate in the downstream profits generated from pharmaceutical products our platform has enabled. By marketing our platform directly to the public, we intend to make comprehensive genotype screening solutions accessible to people all over the world via the internet. Our system will enable a more holistic approach to using genomics information to improve peoples lives.
The patient of the future will have more information and power than ever imagined. The human genome project, the internet and recent technological advancements all contribute to make this possible, and we intend to take advantage of these synergies to become the primary conduit for the generation and distribution of personalized genetic information.
The Market
Pharmacogenomics is currently a 1 billion dollar industry and is projected to be a 10 billion dollar industry by the end of 2003. Several billions of dollars have been spent on the human genome project so far, and an equal amount will likely be spent trying to understand what all of the genomics information means (i.e. bioinformatics, proteomics and phenomics). Genomics is a multi billion dollar industry world-wide and the market for personalized medicine is expected to exceed $25 billion dollars by 2010. Recently congress has approved a $2.3 billion increase in NIH funding to a total of $18 billion dollars for the year 2000.
2.FOUNDERS
Tony Frudakis, Ph.D.(tfrudakis@dnaprint.com)
Chief Executive Officer, President and Laboratory Director. Dr. Tony Frudakis is a Phi Beta Kappa, Magna Cumme Laude graduate of the University of California system. He received his doctorate degree in molecular and cell biology from the University of California Berkeley and has 14 total years of experience as a molecular biologist. Dr. Frudakis' technical experience encompass a range of areas within biology, including the molecular biology of eukaryotic transcriptional regulation, the creation and study of transgenic animals, the development of novel nucleic acid isolation techniques and gene discovery protocols, bioinformatics processing and anatomical gene expression profiling. At Corixa Corporation in Seattle, WA he developed several new techniques for RNA fingerprinting, managed and executed high-throughput gene discovery programs for various cancers and was instrumental in the companies early success in attracting R and D partners. Founding GAFF biologic in 1998, Dr. Frudakis established a good reputation for high quality DNA sequencing and library construction/screening services, until its evolution into the DNAPrint Genomics that exists today. In all, his work has resulted in a patent portfolio for over 350 unique genes and 2 products
George Frudakis(gfrudakis@dnaprint.com)
Vice President of Business Affairs. George Frudakis has vast experience with start-up company development. He started and developed a successful multi-component company called GAFF group, which today enjoys over 15 million dollars annually in revenue. During his life’s work as an entrepreneur and businessman, George has learned how to run and successfully manage the financial and operational aspects of both small and large companies alike. He is a graduate from the California State University at Long Beach in California.
Myung Ho Kim, Ph.D. Mathematics(mkim@dnaprint.com)
Director of Informatics and Lead Mathemetician. Myung recieved his Ph.D. in Mathematics from the University of Michigan in Ann Arbor in 1988 and M.S. in Mathematics from The Ohio State University in Columbus Ohio. Most recently, Myung worked on the Ant World Server project supported by DARPA (Defense Advanced Research Progect Agency) and implemented Kolmogorov-Smirnov tests, linear/nonlinear regression, nonparametric analysis and modeling to a TREC 6 (Text Retrieval Conference) project using SAS, C/C++ and Perl languages. Prior to this, Myung simulated mathematical modeling for breast tumors and implemented/developed various image processing algorithms. He has served as an Honorary research Fellow in the Department of Mathematics and Information Science at the University of Auckland, New Zealand and a Visiting Research Scholor in the Department of Mathematics at the University of California at Santa Cruz in California. Prior to coming to the United States, Myung held the position of Assistant Professor in the Department of Mathematics at Sungkyunkwan University in Soel Korea.
Venkateswarlu Kondragunta, Ph.D. (vkondragunta@dnaprint.com)
Director of Biostatistics. Dr. Kondragunta obtained his Ph.D. in Statistics from the University of Madras, Madras, India. He most recently served as a Postdoctoral Fellow at the Schoolof Public Health, University of Texas, Houston, TX under the tutelage of Dr. Ranajit Chakraborty, one of the most famous and accomplished genetic mathematicians in the world. His research interests include variance components, linear regression models, general linear models, design and analysis, discriminant analysis, principal component analysis and statistical genetics. He has taught courses in Variance Components, Design and Analysis of Experiments and Linear Regression Models and Probability Theory at Concordia University in Montreal, Canada. Dr. Kondragunta is an accomplished programmer and has amassed considerable experience with implementing statistical genetic ideas into C++, S-plus, FORTRAN (7 years experience) and JAVA code. His most recent work used the REG, ANOVA, GLM, VARCOMP, CANDISC, CLUSTER, DISCRIM, FACTOR, PRINCOMP and LOGISTIC tools in the SAS computing environment on real and simulated data sets.
A partial list of publications for Dr. Kondragunta include:
Chaubey, Y.P. and K.Venkateswarlu. A numerical study of some robust estimators of variance components in one-way model. International Indian Statistical Association Conference proceedings, October 10-11, 1998, McMaster University, Hamilton, Canada.
Venkateswarlu, K. K.N.Ponnuswamy, and M.R.Srinivasan. Estimation of variance components based on diallel model. Mathematical Biosciences, V-150, 105-112.
Venkateswarlu, K, and K.N.Ponnuswamy. Estimation of variance components based on bio-model of diallel crosses (balanced). Communications in Statistics (Theory & Methods), Vol-27, 139-152.
Venkateswarlu, K. Estimation of variance components based on diallel model involving maternal and maternal interaction effects. Biometrical Journal, Vol-39, 287-295.
3.PRODUCTS&SERVICES
see dnap web page for a complete description of products & services http://www.dnaprint.com/
SNiPdocTM
High-throughput SNP profiling-To help us with our bottom line, we provide contract SNP profiling services to the drug development community. We call this service our SNiPdocTM service, and it is targeted towards pharmaceutical companies. Many pharmaceutical companies are seeking to enter into the field of Pharmacogenomics. This new field of study could have a dramatic impact on overall health care costs in the future. Furthermore, by having access to pharmacogenomics data, pharmaceutical companies can focus their clinical trials on segments of the population that are genetically receptive to the treatment. Experimental drugs can be targeted to individuals of a particular genotype, and genetic variations shown to underlie a poor-response to a trial drug could be used as a basis for eliminating the non-responding segment of the trial population from the study. In this way, pharmaceutical companies can reduce drug trial failures and the costs associated with them. Contracting this work out to service providers is a viable option for many smaller pharmaceutical companies who do not have the volume of work necessary to justify the price of the equipment and expertise. At DNAPrint Genomics, we offer multiple patient – multiple SNP sampling matricies designed on a custom, semi-custom or predefined basis. We can use our proprietary PhenomixM databases of medically relevant SNPs (numbering in the thousands of SNPs at present), or design chips for your application de-novo. We will work with your scientists to develop the experiments from beginning to end, that suit your needs, and we can handle your project from blood/tissue or DNA starting points. Data handling will be customized for each client; data can be deposited in our secure SNP relational databases system offering you the option of accessing your data over the internet. Alternatively, we can burn and hand-delivered CDs to you. As we develop our data mining algorithms, you will have access to some of the most revolutionary SNP pattern finding tools available anywhere. Using smart PhenomixSM could help you identify overlapping sets of genotypes associated with various phenotypes and/or phenotypic responses, which you might otherwise miss if you conducted your studies on your own or through another less-specialized facility.
DNAPrintTMSTaR
STR typing - (so-called DNA testing) for the public and forensic community, including paternity and maternity testing. STR typing differs from SNP profiling in that it looks at only a few inter-genic regions of DNA. Therefore, it is useful only for individual identification and pedigree analysis, and tells nothing about an individuals phenotype. This kind of testing is commonly referred to as DNA testing and is the basis for forensic DNA science used by local and federal law enforcement. We use 7 or 13-locus tests to offer up to 1 in 2 billion resolution power. All tests are performed on PE Applied Biosystems 310 genetic analyzer using PE Profiler and Profiler Plus AMPlFSTRTM kits.
SeaQuickTM
DNA sequencing - There are an abundance of contract DNA sequencing services in operation today. Ours is unique because we offer the customer a seamless web-based interface for submitting, retrieving, manipulating and storing their data files. To date, no other service of this kind exists because it is difficult to design software that is compatible with the complicated DNA sequencing files (called a chromatogram - a series of colored peaks with the corresponding nucleotide sequence identity above each peak). We operate our service through a unique web-capable relational database management system (RDMS), which will be available by early April. Our system is used to collect sequencing requests from customers though a web-based interface, use the requests to build sample sheets for sequencing and organize chromatogram files by customer, project and library. The customer will use the system, through web-pages, to make their orders and retrieve their data from remote locations or their home laboratory. All chromatogram files are processed through the phred basecalling algorithm to give reads and quality values. The resulting reads are then compared to a set of vector sequences (UniVec from NCBI) and the E. coli genome. Customers can retrieve chromatogram files and sequences as quality trimmed, vector masked or unedited files. E. coli sequences can be excluded.
Home DNA specimen Collection Kit
We manufacture a home DNA specimen collection kit called the DNAPrintTM kit. The kit enables the collection of DNA for indefinite storage. A foam tipped swab is used to rub the inside of the subjects cheek. Tiny cells rub off onto the swab and each cell contains DNA. The oral sample is then deposited by contact to a preservative card. The card is sealed in a tamper resistant pouch with a desiccant pack and can be indefinitely stored in a filing cabinet or safe. We use this system as a starting point for genetic analysis because of its durability and convenience. Only takes 10 minutes-bloodless,painless,convenenient
Interested in becoming a retailer? Call toll free 1(877)DNA-file (1-877-362-3453)
We also offer the kit for sale to the public.
It is useful for:
Child security, as a reference record or practical addition to a baby book or family album.
Genealogical "cornerstone" records for adults.
Estate planning, as evidence to disprove illegitimate paternity claims against your estate after death.
A gift for the person that has everything.
Collect and store your sample at home(ex. a filing cabinet) or send it to us for certified storage.
CNN live will have a special on at the top of the hour about "IT"..."GINGER" what is it? Is the topic.
Good luck all. I'll stop posting about "IT" now.
CNN live speaking of "IT" right now.
"IT" featured on CNBC @ 6:30 ET TONIGHT!*EOM
I copied this info off of another board. I won't be home tonight to watch this. But I'm sure if "IT" is big, we'll be seeing plenty of more new articles on it.
RMOO spread is as tight as I've seen it. Also, I tried to buy more of SKGV when the Ask dropped to $.05. They raised the Ask back up to $.055. It was only at $.05 for a few minutes.
Good luck everyone.
Thanks for the info. RMOO is also holding up pretty well. I know that it has been stated before that we hope that RMOO responds like ESYG did post split. I would be happy if it did half that.
You're right, there have been a lot of winners on this board.
Great board!
Good morning Patsy,
I have seen this morning that you have found info on NYBDY. I saw that the O/S is 5,000 and the float is 3,000. Do you think that they might do a forward split? Have you taken a position in it?
Good luck
RMOO did well today. I know that we still have 5 weeks left until the split so it'll probably go up and down until then. But I think that it is a good sign to see it up on such low volume.
Good luck all.
RMOO is doing extremely well! Reminds me ESYG. I wonder why they are letting this one go?
10-1 forward split on Feb 16
Good luck all
Sorry about the venting on SKGV.
I'm sick of the MMM on SKGV.
I hope that some of you people are making money today.
GAMZ looks like it has been doing extremely well for the past week or so.
Good luck to all.
I don't know what the heck is going on with SKGV.
They just won't let it move higher.
Good luck all.
SKGV
The Bid and the Ask are both $.06. Volume jumped from 70,000 shares up to 300,000 within a few minutes. Even on Monday when we only traded 15,000 shares the ask changed more.
I'm still upset with this action. Some thing just doesn't seem right.
We'll see.
Good luck all
Thanks Patsy,
I can't believe this $hit!
I hope that you can find out what happened.
I am just absolutely stunned. Today this stock acted like it just came off of a reverse split instead of a forward split. I was expecting any type of news to propel this stock sky ward.
And in my opinion the announcement of this guy is great news. It's not like he is just Joe Blow off of the streets.
I'm dazed, confused, and frustrated. Yet I still think that this should pop. This has everything going for it except the price.
Good luck Patsy.
SKGV Am I wrong at asking how in the heck can they keep this down. We have an incredible volume of mostly buys today. And I feel that for this company to get this guy onboard is unbelievable.
I'll be waiting for the dust to clear. This should have popped! Why would the MM's keep lowering the price?
I'm stumped.
Take it easy everyone. I'm going to try to.
Larry
SKGV News will be out Today! Good Luck All!
An exciting SkyGivers public announcement will be made today. Mr. David Starr, CIO of 3-Com has agreed to become Chairman of our Technology Advisory Board. Mr. Starr will provide counsel on all technolgy decisions. He is one of the world's foremost experts in information technology. More details about his background will be given in the press release. We are very pleased and excited to have Mr. Starr join our SkyGivers team.
I would be extremely upset if i had been in that stock and they did that.
Patsy, you said that you had been in this one, right?
SKGV 300,000 shares traded today. That is huge. I think that some people couldn't hang around any longer. The bid only went down a 1/2 cent. So I would think that we have bottomed out. If anyone is buying in they are getting a very decent purchasing price.
Still awaiting news. I don't understand the delay. COOX just made me understand the importance of holding on to at least some of your shares for a little while longer. (So did ESYG)
I still feel that SKGV will do well. I only see the selling as helping the share holders when this starts to run. IMHO
Good luck to all!
(500%)Does anyone know why COOX blew up today?
I check that stock daily and there has been no trading for quite some time. And today it trades around 170,000 shares and goes up 500%.
Esyg News.
eSynergies Signs Letter of Intent to Acquire Salesmation And Its Subsidiaries for $45 million
SANTA BARBARA, Calif., Jan 8, 2001 /PRNewswire via COMTEX/ -- eSynergies, Inc.
(OTC Bulletin Board: ESYG) announced today that it has signed a letter of intent
to acquire 100% of the outstanding shares of Salesmation and its group of
companies for a minimum of $45 million in stock. Upon completion of this
transaction, eSynergies will become a next generation e-business application
service provider (ASP) offering a Web-based plug-n-play platform to integrate
and automate old economy and new economy business applications without hardware,
software, downloads or training.
The Salesmation group of companies include Salesmation, M2(M-squared) Limited
and CommerceSwitch. The three companies have audited consolidated revenues of
just under $5,000,000 for the last fiscal year. With almost no debt and two of
three divisions being cash flow positive, the combined companies have a clear
path to profitability over the next 12 months. "The Salesmation group of
companies have built cutting edge automation technologies in the
Business-to-Business (B2B) infrastructure, Customer Relationship Management
(eCRM) and Globalization industries," said Thomas Ronk, Salesmation's Chairman.
With only $4,000,000 in investment capital Salesmation attained nearly
$5,000,000 in revenues in its first year as a consolidated company. "We have a
proven business model that is scalable for rapid growth and expanding profit
margins," he added.
After the acquisition is complete, eSynergies will boast over 800 clients
worldwide, including the Government of South Africa, Sabre, American Airlines,
U.S. Department of Commerce, DoubleClick, Quiksilver, Canon, Smith Kline
Beecham, Enterprise Rent-a-Car, Bulk Register.com, Eprise and United Airlines.
Partnerships include Blaze Software / Brokat, iLux, Saqqara, Acxiom, Crunchy,
InfoUSA, NetCreations and WebTrends.
This new application integration service provider platform allows eSynergies to
compete across multiple industries. Research from Jupiter Communications and IDC
states that the B2B transaction market will exceed $6 trillion, $4 trillion of
which will require globalization services due to transactions occurring outside
the United States. Outsourcing technology to Application Service Providers
(ASPs) will represent a growing share of the $99 billion Internet Services and
$177 billion Outsourcing markets. Online advertising revenues are expected to
reach $28 billion, CRM will approach $12.1 billion and e-mail marketing will
grow to $7.3 billion over the next four years.
"In order to take advantage of this overwhelming growth, businesses must begin
to incorporate Internet strategies throughout their procurement and sales
processes, translate and globalize their Web sites into multiple languages and
invest in multiple selling models to penetrate worldwide markets and protect
market share," said Marcy Engelbrecht, President of eSynergies.
The Salesmation ASP includes powerful eCRM capabilities combined with recent
breakthroughs in rules engine technology to enable businesses to connect brick
and mortar back office applications to major e-business applications using
pre-built adapters. Business managers can design and execute complex
advertising, marketing and sales campaigns based on online click stream, offline
demographic and all types of legacy database information. Business logic can be
entered into the system from the Salesmation Web site and users can automate
most any business process without the help of programmers or IT staff. By
integrating multiple disparate data sources and automating best business
practices, Salesmation provides the platform necessary to leverage existing IT
infrastructure to break the cost barrier of next generation Internet
applications.
M2 Limited has been providing translation and globalization services for over 20
years and will complement the eSynergies ASP platform by providing language
translation and globalization in 48 languages. M2 helps companies leverage
content from multiple sources by automating the exchange of data between
multiple applications, formats and character sets. After the acquisition is
complete, M2 will provide an open integration framework providing a
collaborative environment that increases productivity by allowing translators
worldwide the ability to view and edit dynamic content as it appears on the Web
page, a critical necessity in globalizing database-driven sites. This will
enhance M2's ability to localize its customers' Web sites through more efficient
project management of global resource allocation.
CommerceSwitch markets and sells a Web-based content management and B2B exchange
ASP service that converts product catalogs into XML and automates the submission
of those products into any of the major B2B exchanges and net markets. By
transforming, managing and exchanging product content, CommerceSwitch provides a
complete product management and exchange solution that drives increased sales
and buyer loyalty throughout the e-commerce channel. Its B2B supplier solution
aggregates and integrates digital product content, maintains accurate and
up-to-date product information and delivers content in any format (XML, cXML,
xCBL, CIF, RosettaNet, etc) by automating the submission of products into Ariba
and CommerceOne powered B2B exchanges and net markets.
By leveraging a company's existing infrastructure investment and valuable
technical assets, the eSynergies ASP platform can transform an organization into
an intelligent enterprise with powerful strategic competitive advantages.
RMOO Announcement of split.
http://biz.yahoo.com/prnews/010108/fl_raven_m.html
ESYG was RCVR before the split.eom
The first people to buy RCVR might have boughten it around $.25, but then it jumped to $.75 and by the end of the day it was $1.75 or so. I know that there couldn't have been many buys under $.75.
I bought in at $1.65 and still made an 800% profit when I sold for an average of $1.31. So it may well be over a 20 bagger now to anyone who stayed in.
I hope RMOO will be similar.
Good luck to you.
Patsy ESYG has rebounded extremely well!!!!!
I can only hope that RMOO can trade similar to this.
I saw your post on RB from the RMOO board. I was writing you an e-mail and rereading the one you sent me, and I thought that might have been you buying in.
Good luck to you.
ESYG....is still going up. It jumped right up on only 1,500 shares and now has gone up higher with 2,000 more shares traded.
Good luck to all today.
I hope to see the same trend in the future with SKGV and RMOO. I'll just have to wait and see.
SKGV had a great last half-n-hour rally today. I hope that we will see news soon.
I hope everyone had a good day today.
An incredible day for the markets. I was happy to be at home to see the market rally. I've never seen anything like it.
Good luck to all.
Patsy, are you checking out ESYG. 17,000 in volume has moved it up $.55. Looks like if you want to sell you had better sell in small blocks.
Good luck to you.
SKGV finished up 45% today.
Patsy, that is a real good sign of what potential this stock has when you can't even get 20,000 shares filled at one certain price.
And E*Trade just told me that it could be 2 weeks before I get my shares. They don't know ####! But I am waiting to sell anyway.
RMOO will split on Jan 11.
Good luck to you.
Hello Patsy and all,
There looks to be a few good split plays out there right now.
RMOO will do a 10-1 forward split on Jan 11.
WWFI prbably will have a 30-1 split in the near future.
And SKGV should be getting some news out soon. They were formerly WTPE and did a 48-1 forward split Dec 21.
PEDN
NRES
Good luck.
RMOO....
This is copied off of RagingBull. (10-1 forward split)
Finaly found some news on RMOO
Over-the-Counter Bulletin Board Winners
(To subscribe to our daily Winners and Losers Newsletter e-mail
cidea2@yahoo.com)
Winners
Raven Moon International (RMOO: OTCBB) gained 708% today to close at $1.01.
Joey DiFancesco, the company's Chairman and CEO, said, "We are currently
working on a television production, and we are in the process of shooting it
now. We signed a contract with a major distributor, so maybe some word hit
the street."
"We haven't released it to the press or anybody yet, but apparently it is
leaking out," said Joey.
"Things are leaking out about our TV show for children and the distribution
contract we signed." He said Raven Moon signed a deal with DLT Entertainment
who is located in New York, Los Angeles, and London; they are television
distributors and syndicates.
IFOA.....Wow! What a finish. Patsy, I know a win is a win. And you should count your blessings you made money, but I would feel some what bad knowing that I sold out a few hours early on this one.
We have all done this thou. It is better to have made something then it is to lose anything. I know all to well how it feels to lose on these stocks.
Good luck to you.
IFOA looks like it worked out for you again. Congtats! Also, ESYG has moved up a little bit more today. You seem to have a good system. I also see that your PCES is up.
Do you ever lose money? Just a joke, no need to answer.
I'm still waiting on SKGV and RMOO.
I hope you have a wonderful New Year. And thanks for your help with these stocks. I appreciate it.